Ch 30 principles of pharmacology

Option D: A weak base with a pKa of 7 enhances diffusion across biological membranes due to its ability to exist in a non-ionized form at physiological pH. This non-ionized form can readily cross lipid membranes, facilitating access to the site of action.

Option A: Hydrophilicity generally hinders diffusion through lipid membranes, as water-soluble substances struggle to penetrate the lipid bilayer.

Option B: Large molecular size typically restricts a drug's ability to diffuse across membranes, as larger molecules face greater difficulty in navigating through the lipid layers.

Option C: A weak acid with a pKa of 7 would be primarily ionized at physiological pH, limiting its ability to diffuse across membranes effectively.

Takeaways: The ability of a drug to diffuse across biological membranes is significantly influenced by its ionization state, with weak bases being more favorable for diffusion due to their non-ionized forms at physiological pH, which requires understanding the principles of drug absorption and distribution for effective pharmacotherapy.

Option C: Chronic hepatitis C infection is effectively treated with interferons, specifically pegylated interferon, which enhances the immune response against the virus. This treatment is a standard part of the therapeutic regimen for managing chronic hepatitis C, aiming to achieve sustained virological response and improve liver function.

Option A: Herpes simplex encephalitis is primarily treated with antiviral medications such as acyclovir, not interferons, which are not indicated for this condition.

Option B: Chronic hepatitis B infection is typically managed with antiviral agents like tenofovir or entecavir rather than interferons, which are less commonly used in this context.

Option D: Hairy cell leukaemia is treated with purine analogs such as cladribine or pentostatin, and while interferons have been used in the past, they are not the primary treatment choice today.

Takeaways: Interferons are specifically indicated for the treatment of chronic hepatitis C infection, enhancing the immune response against the virus, which requires appropriate management strategies for hepatitis C to ensure effective patient care.

Option A: Constant amount of the drug is eliminated per unit time is not true for first-order kinetics, where the elimination rate is proportional to the drug concentration. This means that a constant fraction of the drug is eliminated over time, not a fixed amount.

Option B: Fixed t1/2 is true in first-order kinetics, as the half-life remains constant regardless of the drug concentration, allowing for predictable pharmacokinetics.

Option C: There is steady-state plasma concentration is accurate, as first-order kinetics allows for a stable concentration to be achieved with continuous administration of the drug.

Option D: Elimination rate is directly proportional to plasma concentration is a defining characteristic of first-order kinetics, where higher concentrations lead to a greater elimination rate.

Takeaways: In first-order kinetics, the elimination rate is proportional to the plasma concentration, leading to a fixed half-life and the potential for steady-state concentrations, which requires understanding pharmacokinetics for effective medication management.

Option A: Triazolam is a benzodiazepine that can cause prolonged sedation, and its effects can be reversed by flumazenil, a benzodiazepine antagonist. This makes it the correct choice as it aligns with the question's description of a drug whose toxic dose results in prolonged sleep.

Option B: Buspirone is an anxiolytic that does not produce sedation in the same manner as benzodiazepines and is not reversed by flumazenil.

Option C: Pentobarbital is a barbiturate that can cause prolonged sedation, but flumazenil does not reverse its effects, as it specifically targets benzodiazepines.

Option D: Phenobarbital is also a barbiturate and similarly cannot be reversed by flumazenil, which is specific to benzodiazepines.

Takeaways: Understanding the pharmacological properties of benzodiazepines, such as triazolam, and their reversal with flumazenil is crucial for managing overdose situations effectively, as outlined in MedlinePlus on benzodiazepine overdose.

Option D: Rifampicin is a well-known enzyme inducer that significantly increases the metabolism of various drugs by inducing cytochrome P450 enzymes, particularly CYP3A4. This property is crucial in clinical settings as it can affect the efficacy of co-administered medications, necessitating dosage adjustments.

Option A: Phenytoin does induce certain enzymes, but it is primarily recognized for its role as an anticonvulsant rather than a primary enzyme inducer compared to rifampicin.

Option B: Carbamazepine is also an enzyme inducer, but it is less potent than rifampicin and is primarily used for seizure control and mood stabilization, not as a first-line enzyme inducer.

Option C: Phenobarbitone is an enzyme inducer; however, it is not as commonly referenced as rifampicin in clinical practice for this role, making it less relevant in this context.

Takeaways: Enzyme inducers, such as rifampicin, play a critical role in pharmacokinetics by increasing the metabolism of drugs, which can necessitate dosage adjustments for effective therapy. Understanding these interactions is essential for safe medication management, especially when considering drug interactions in patient care.

Option C: Diarrhea is a troublesome side effect of codeine is not true. Codeine is an opioid that typically causes constipation rather than diarrhea, making this statement factually incorrect. Opioids like codeine slow gastrointestinal motility, leading to constipation, which is a common side effect.

Option A: Codeine inhibits the cough center in the medulla, which is a true statement. It acts centrally to suppress the cough reflex, making it effective as an antitussive.

Option B: Codeine is indeed a less potent antitussive than morphine. While both are opioids, morphine has a stronger analgesic and antitussive effect compared to codeine.

Option D: Codeine is classified as an analgesic, which is accurate. It provides pain relief and is often used for mild to moderate pain management.

Takeaways: Codeine is an opioid analgesic that inhibits the cough center and is less potent than morphine; it typically causes constipation rather than diarrhea, which requires understanding opioid side effects for effective patient management.

Option A: Potassium chloride is commonly associated with phlebitis when administered intravenously due to its irritant properties. The high osmolarity and acidic nature of potassium chloride can cause inflammation of the vein, leading to phlebitis, especially if infused rapidly or in concentrated forms.

Option B: Hydrocortisone is a corticosteroid that is less likely to cause phlebitis when given intravenously. It is generally well-tolerated and does not possess the same irritant properties as potassium chloride.

Option C: Diazepam can cause venous irritation but is not as commonly associated with phlebitis as potassium chloride. Its formulation can lead to discomfort, yet it is not a primary cause of phlebitis in clinical practice.

Option D: 50 per cent glucose solutions can lead to complications like hyperglycemia but are not typically linked to phlebitis. The risk of phlebitis is more closely associated with irritant medications rather than hypertonic glucose solutions.

Takeaways: Understanding the irritant properties of intravenous medications, such as potassium chloride, is crucial for preventing complications like phlebitis, which requires proper administration techniques and monitoring to ensure patient safety.

Option A: The intensity of the pharmacologic action of a drug is most dependent on the concentration of the drug at the receptor site. This concentration directly influences the binding affinity and efficacy of the drug, determining how effectively it can elicit a therapeutic response. Higher concentrations typically result in greater pharmacological effects, making this factor crucial in drug action.

Option B: The elimination half-life (t_½) of the drug affects how long the drug remains active in the system but does not directly determine the intensity of its action at the receptor site.

Option C: The onset time of the drug after oral administration relates to how quickly the drug begins to exert its effects, but it does not influence the intensity of the pharmacologic action once the drug reaches the receptor site.

Option D: The minimum toxic concentration (MTC) of the drug in plasma indicates the threshold for toxicity but does not correlate with the intensity of the drug's therapeutic action at the receptor site.

Takeaways: The intensity of a drug's pharmacologic action is primarily determined by the concentration of the drug at the receptor site, as this directly impacts its efficacy and therapeutic response, requiring careful monitoring of drug levels to ensure optimal treatment outcomes.

Option D: Buspirone/panic attack. Buspirone is primarily used for the treatment of generalized anxiety disorder and is not indicated for acute panic attacks, which typically require faster-acting medications such as benzodiazepines.

Option A: Diazepam/muscle spasticity. Diazepam is correctly matched as it is effective in treating muscle spasticity due to its muscle relaxant properties.

Option B: Midazolam/anesthesia. Midazolam is accurately matched as it is commonly used for sedation and anesthesia induction due to its rapid onset and short duration of action.

Option C: Clonazepam/epilepsy. Clonazepam is appropriately matched as it is utilized in the management of epilepsy, particularly for certain seizure types.

Takeaways: Understanding the specific indications for medications like buspirone, which is not suitable for panic attacks but rather for generalized anxiety disorder, is crucial for effective pharmacological management; this requires knowledge of anxiety disorders and their treatments.

Option C: Bran/milk of magnesia serves as a suitable indication for constipation with low bulk stool due to its ability to increase stool bulk and promote bowel movements through osmotic action. Bran provides dietary fiber, while milk of magnesia acts as a saline laxative, both contributing to improved stool consistency and frequency.

Option A: Loperamide is an opioid antidiarrheal that reduces bowel motility and is used to treat diarrhea, not constipation. It does not address the need for increased stool bulk.

Option B: Paraffin oil is a lubricant laxative that may ease stool passage but does not increase stool bulk. It is not the best choice for addressing low bulk stool specifically.

Option D: Bisacodyl and castor oil are stimulant laxatives that induce bowel movements but do not effectively address the underlying issue of low bulk stool. They may lead to cramping and are not suitable for chronic use.

Takeaways: Bran and milk of magnesia effectively increase stool bulk and promote regularity, making them ideal for treating constipation with low bulk stool, as outlined in MedlinePlus on constipation treatments.

Option D: Amitriptyline decreases the rate of gastric emptying due to its anticholinergic properties, which slow gastrointestinal motility. This medication is often used in the treatment of depression and chronic pain, but it can lead to delayed gastric emptying as a side effect, impacting digestion and absorption of medications and nutrients.

Option A: Aspirin overdose does not primarily affect gastric emptying; instead, it can lead to gastrointestinal irritation and bleeding. The primary concern with aspirin overdose is toxicity rather than altered gastric motility.

Option B: Migraine may cause nausea and vomiting, but it does not inherently decrease gastric emptying. Migraines can affect gastrointestinal function temporarily, but they do not have a direct pharmacological effect on gastric motility.

Option C: Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), does not significantly impact gastric emptying. While SSRIs can influence gastrointestinal function, they are not known to delay gastric motility like amitriptyline does.

Takeaways: Amitriptyline's anticholinergic effects lead to decreased gastric emptying, which is important for managing patients on this medication. Understanding these effects is crucial for optimizing treatment and requires patient education regarding potential side effects to ensure safe medication use.

Option C: Epinephrine is the agent of choice for anaphylactic reactions due to its ability to rapidly reverse the symptoms of anaphylaxis, including bronchoconstriction and hypotension, by acting on alpha and beta-adrenergic receptors. It increases vascular tone and improves airway patency, making it essential in emergency treatment.

Option A: Clonidine is an alpha-2 adrenergic agonist primarily used for hypertension and does not have the necessary effects to counteract anaphylaxis. It does not address airway obstruction or vascular collapse.

Option B: Isoproterenol is a non-selective beta-adrenergic agonist that can increase heart rate and bronchodilation but lacks the alpha-adrenergic activity necessary to effectively treat anaphylaxis, particularly in managing hypotension.

Option D: Phenylephrine is a selective alpha-1 adrenergic agonist used primarily as a decongestant and for increasing blood pressure. It does not provide the bronchodilation needed in anaphylactic reactions and is not suitable for this emergency.

Takeaways: Epinephrine is the first-line treatment for anaphylaxis due to its dual action on alpha and beta receptors, which is crucial for reversing severe allergic reactions and requires immediate administration during anaphylactic emergencies.

Option B: The maximum recommended daily dose in adults is 4 gm, which is crucial for preventing hepatotoxicity while ensuring effective analgesia. Paracetamol is widely used for pain relief and fever reduction, and adherence to this dosage is essential for safe use.

Option A: Paracetamol is primarily metabolized in the liver and is not excreted unchanged by the kidneys; instead, it is converted to metabolites before renal excretion.

Option C: Paracetamol exhibits minimal anti-inflammatory activity compared to NSAIDs, making it less effective for conditions requiring strong anti-inflammatory effects.

Option D: Paracetamol can be safely administered to patients with an allergy to aspirin, as it does not belong to the same class of medications and has a different mechanism of action.

Takeaways: Understanding the maximum recommended daily dose of paracetamol is essential for safe administration, as exceeding 4 gm can lead to liver damage; thus, proper dosing guidelines must be followed to avoid complications, which requires patient education on safe paracetamol use.

Option C: Ranitidine acts as a reversible competitive antagonist of histamine H2 receptors, effectively reducing gastric acid secretion. This mechanism is crucial in treating conditions like peptic ulcers and gastroesophageal reflux disease, making it a key pharmacological agent in managing acid-related disorders.

Option A: Suxamethonium is a depolarizing neuromuscular blocker, not a reversible competitive antagonist. It works by causing persistent depolarization of the motor end plate, leading to muscle paralysis.

Option B: Loratidine is an antihistamine that selectively antagonizes peripheral H1 receptors, but it does not function as a reversible competitive antagonist in the same context as ranitidine does with H2 receptors.

Option D: Phenoxybenzamine is a non-selective, irreversible alpha-adrenergic antagonist. Its irreversible binding to receptors distinguishes it from reversible competitive antagonists like ranitidine.

Takeaways: Ranitidine exemplifies a reversible competitive antagonist by blocking H2 receptors to decrease gastric acid secretion, which is essential for treating acid-related conditions; understanding this mechanism requires knowledge of pharmacodynamics and receptor interactions.

Option C: Gentamicin is the most appropriate treatment for this patient, as it is an aminoglycoside antibiotic effective against gram-negative bacteria like Escherichia coli. Given the patient's renal insufficiency, dosing must be carefully adjusted to avoid toxicity, but gentamicin remains a suitable choice for treating urinary tract infections in this context.

Option A: Chloramphenicol is not a first-line treatment for urinary tract infections and poses a risk of serious side effects, including bone marrow suppression, which is particularly concerning in patients with hepatic insufficiency.

Option B: Erythromycin is primarily effective against gram-positive bacteria and is not suitable for treating infections caused by Escherichia coli, which is a gram-negative organism.

Option D: Penicillin is generally ineffective against Escherichia coli, as many strains produce beta-lactamases that confer resistance to this class of antibiotics.

Takeaways: Effective treatment of urinary tract infections caused by Escherichia coli often requires the use of aminoglycosides like gentamicin, especially in patients with specific comorbidities, necessitating careful dosing adjustments in renal insufficiency.

Option C: Days 18 to 55 after conception is the critical period for organogenesis, where the fetus is particularly vulnerable to teratogenic effects of medications, including vitamin A derivatives. During this time, exposure can lead to significant birth defects, making it the highest risk period for the developing fetus.

Option A: Before conception does not apply as the teratogenic effects of the drug would not affect the embryo until after conception has occurred.

Option B: Days 1 to 17 after conception is primarily the pre-implantation phase, where the embryo is less susceptible to teratogens as it has not yet implanted in the uterine lining.

Option D: Days 56 to birth is a later stage of fetal development where the risk of structural defects decreases, although functional defects may still occur.

Takeaways: The period of greatest risk for developing birth defects due to teratogenic exposure, such as vitamin A derivatives, occurs during days 18 to 55 after conception, which requires careful monitoring of medication use during pregnancy.

Option D: Cisplatin is recognized as a highly emetogenic anticancer drug due to its potent ability to induce nausea and vomiting through central nervous system mechanisms. It is essential for healthcare providers to anticipate and manage these side effects effectively to improve patient comfort and adherence to treatment.

Option A: Cyclophosphamide, while it can cause nausea, is classified as moderately emetogenic rather than highly emetogenic, making it less likely to induce severe vomiting compared to cisplatin.

Option B: Methotrexate is also considered moderately emetogenic and does not possess the same level of emetogenic potential as cisplatin, thus requiring less aggressive antiemetic prophylaxis.

Option C: 5-Fluorouracil is categorized as low to moderately emetogenic, which means it is less likely to cause significant nausea and vomiting compared to highly emetogenic agents like cisplatin.

Takeaways: Understanding the emetogenic potential of anticancer drugs, such as how cisplatin requires proactive antiemetic management to mitigate nausea and vomiting, is crucial for effective patient care.

Option B: When the extraction ratio is less than 0.2, clearance is primarily determined by the enzyme activity in the liver, making it enzyme-dependent. This indicates that the drug's clearance is significantly influenced by metabolic processes rather than blood flow, which is crucial for understanding pharmacokinetics.

Option A: Clearance is not directly useful in calculating loading doses, which are determined by volume of distribution and desired plasma concentration, rather than clearance rates.

Option C: Clearance is directly proportional to blood flow to the clearing organ; as blood flow increases, clearance typically increases as well, contrary to the statement.

Option D: Lipid solubility generally decreases renal excretion of drugs, as more lipid-soluble substances are reabsorbed in the renal tubules rather than excreted, contradicting the assertion.

Takeaways: Clearance is a critical pharmacokinetic parameter that reflects the efficiency of drug elimination, particularly influenced by enzyme activity when the extraction ratio is low, requiring a solid understanding of drug metabolism and clearance mechanisms for effective medication management.

Option D: The apparent volume of drug distribution (Vd) can be calculated using the formula Vd = Dose / Concentration. Here, Vd = 100 mg / 20 µg/mL, which converts to 100,000 µg / 20 µg/mL = 5,000 mL or 5 L. This indicates that the drug is widely distributed in the body, consistent with fluconazole's pharmacokinetics.

Option A: A volume of 0.5 L does not reflect the calculated distribution based on the given dose and concentration, indicating a misunderstanding of the pharmacokinetic principles involved.

Option B: A volume of 1 L is insufficient to account for the calculated distribution from the provided dose and peak plasma concentration, demonstrating a lack of application of the Vd formula.

Option C: A volume of 3 L also fails to match the calculated distribution, as it does not align with the pharmacokinetic data provided in the question.

Takeaways: The apparent volume of distribution for a drug can be calculated using the formula Vd = Dose / Concentration, which is crucial for understanding how widely a drug disperses in the body and requires knowledge of pharmacokinetics for effective medication management.

Option A: Drug absorption following oral administration is most commonly through passive diffusion, which allows non-polar lipid-soluble drugs to cross cell membranes effectively. This mechanism is crucial for the bioavailability of many medications, as it facilitates their movement from the gastrointestinal tract into the bloodstream without the need for energy or specific transporters.

Option B: Absorption does not predominantly occur in the colon; instead, it primarily takes place in the small intestine, where the surface area and blood supply are optimal for nutrient and drug uptake.

Option C: Drug absorption is not usually complete within 90 minutes, as this can vary widely depending on the drug formulation, gastric emptying time, and individual patient factors, making this statement overly simplistic.

Option D: While non-polar lipid-soluble drugs are absorbed more readily than polar water-soluble drugs, this statement does not encompass the full complexity of drug absorption, which also depends on factors like pH and the presence of food.

Takeaways: Understanding that drug absorption following oral administration primarily occurs through passive diffusion highlights the importance of drug lipophilicity in pharmacokinetics, which requires knowledge of absorption mechanisms for effective medication management.

Option D: The drug aspirin, with a pKa of 3.49, will be most soluble at pH 4.0 because at this pH, a greater proportion of the drug is in its ionized form, enhancing solubility. The Henderson-Hasselbalch equation indicates that as the pH increases above the pKa, the ionized form predominates, leading to increased solubility in aqueous environments.

Option A: At pH 1.0, aspirin is predominantly in its non-ionized form, which decreases its solubility in water. The acidic environment favors the unionized state, reducing the drug's solubility.

Option B: At pH 2.0, while there is some ionization, the majority of aspirin remains non-ionized. This still limits the solubility compared to higher pH levels where ionization increases.

Option C: At pH 3.0, the ionization of aspirin begins to increase, but it is still not maximized. The solubility is better than at lower pH levels but not as high as at pH 4.0 where ionization is optimal.

Takeaways: The solubility of weak acids like aspirin increases as the pH rises above their pKa, leading to greater ionization and solubility; thus, understanding this relationship is crucial for effective drug formulation and administration, which requires knowledge of acid-base balance in pharmacology.